Académique Documents
Professionnel Documents
Culture Documents
To make the diagnosis dan its managements To explain the terminology To explain the etiopathogenesis To explain the pathologic abnormality To inform the clinical symptoms and signs To explain the criteria of diagnosis To perform the general management
EPIDEMIOLOGY
Age :
Mostly in 30-40 yrs Increasing in older patients US Health Examination (1960-62) 0.3% age< 35 th 10.0% age> 60 th
Sex :
ETIOLOGIC FACTOR
Unclear Suggested
Genetic factor,
HLA DR-4
Genetic factors
(HLA DR4)
Arthritogenic
(Bacteri,virus)
Autoimmune
Humoral immunity (RF) Cellular immunity Inflamatory mediators, cytokines
SYNOVITIS
Ag 1
(Ag2 + Ab2)
Arthritis
Synovium inflammation
Phatologic Inflammation of RA
PATHOLOGIC
Synovium inflammation (synovitis) with hypertropic, and villi proliferation tumor-like proliferation (pannus) to damage cartilage, bone and tendon
CLINICAL MANIFESTATION OF RA
History : pain, swelling and morning stiffness of small peripheral joint Often with general symptom ,(general fatigue, Symmetrical arthritis in small peripheral joint Extra articuler manifestation : rare
Early onset of RA
Late stage of RA
Cardiovascular
Pericarditis , myocarditis
Hematology
Mild Anaemia (on chronic disease)
Rheumatoid nodule
DIAGNOSTIC INVESTIGATIONS
Laboratory Test
Anemia (nn) ESR or CR (Good indication of inflamation) Lymphocyteosis Rheumatoid Factor positip (85%) Electrophoresis (increasing of Ig) )
DIAGNOSTIC INVESTIGATIONS
Imaging / X Ray
Normal (in early onset) Soft tissue swelling Periarticular osteopenia Marginal or central erossion and cysts
MANAGEMENT OF RA
Early Diagnosis and early treatment The goal : to achive the remission Patient Education and motivation To suppress the inflamations To perform maximal joint function To protect joint damage The tool : Education Physical rehabilitation Medications Surgical therapy Other : alternatif treatmant By the teams (Ruematologist/Internist, Orthopedist, Physioterapist, Psychiater, Social worker and Family)
MEDICINAL THERAPY
Simptomatis NSAID Glucocorticoid Antiinflammatory dan immunosupressive effect Without disease modifying effect DMARDs (Disease Modifying Anti Rheumatic Drugs) Biologic response modifiers TNF alfa=antagonist, IL1-Ra
Step-down Bridge
Start with multiple drugs (oral Steroid, methotrexate, Sulfasalazine, Chloroqiun, etc) Start with multiple drugs (step by step, stop the most dangerous drug and the last, chloroquin) Continuous until several month-years.
Sulfazalacine
Methotrexate
1-2 mont
1-2 mont
Azatioprine
D-penisillamine